NewAmsterdam Pharma Company N.V. Share Price Börse Stuttgart
Stocks
KH6
NL00150012L7
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.92 EUR | +0.93% |
|
-4.09% | -19.39% |
| 08-06 | RBC Adjusts NewAmsterdam Pharma PT to $50 From $51, Maintains Outperform Speculative Risk Rating | MT |
| 08-05 | NewAmsterdam Pharma Company N.V. - Analyst/Investor Day |
| Market Cap | 2.83B 3.27B 2.64B 2.42B 4.55B 311B 4.62B 30.98B 12.14B 156B 12.27B 12B 516B | P/E 2026 * |
-14.2x | P/E 2027 * | -18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.4B 2.78B 2.24B 2.06B 3.87B 265B 3.93B 26.34B 10.32B 133B 10.43B 10.2B 438B | EV / Sales 2026 * |
91.3x | EV / Sales 2027 * | 16.9x |
| Free-Float |
96.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NewAmsterdam Pharma Company N.V.
| 1 week | -4.09% | ||
| Current month | -1.46% | ||
| 1 month | -21.70% | ||
| 3 months | -9.78% | ||
| 6 months | -17.71% | ||
| Current year | -19.39% |
| 1 week | 22.56 |  | 24.62 |
| 1 month | 22.56 | | 32.38 |
| 3 years | 5.45 | | 35.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Davidson
CEO | Chief Executive Officer | 69 | 31/10/2022 |
Mayur Somaiya
DFI | Director of Finance/CFO | 52 | 22/10/2023 |
Douglas Kling
COO | Chief Operating Officer | 53 | 28/02/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Davidson
BRD | Director/Board Member | 69 | 31/10/2022 |
John Kastelein
BRD | Director/Board Member | 72 | 31/10/2022 |
James Topper
BRD | Director/Board Member | 64 | 31/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.93% | -4.09% | +27.42% | +134.65% | 3.23B | |
| +8.49% | +23.38% | +65.44% | +104.90% | 62.92B | |
| +1.25% | +2.22% | +31.00% | +70.51% | 54.32B | |
| +2.72% | +0.88% | -15.84% | -12.03% | 22.91B | |
| -1.09% | +29.18% | +17.83% | +496.18% | 28.73B | |
| +10.83% | +21.32% | +45.03% | +2.02% | 21.65B | |
| +6.50% | +8.41% | +45.17% | -21.02% | 17.76B | |
| -3.88% | +20.98% | +201.07% | +350.94% | 16.47B | |
| +6.20% | +12.16% | +28.51% | +629.05% | 15.48B | |
| +3.58% | -3.39% | +43.38% | +166.75% | 13.12B | |
| Average | +3.84% | +7.42% | +48.90% | +192.20% | 28.15B | |
| Weighted average by Cap. | +4.19% | +9.95% | +47.31% | +164.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.33M 30.42M 24.57M 22.55M 42.4M 2.9B 43.04M 288M 113M 1.45B 114M 112M 4.8B | 134M 155M 125M 115M 216M 14.76B 219M 1.47B 576M 7.39B 582M 569M 24.46B |
| Net income | -209M -242M -195M -179M -337M -23.02B -342M -2.29B -898M -11.53B -908M -888M -38.15B | -168M -194M -157M -144M -271M -18.52B -275M -1.84B -723M -9.28B -730M -714M -30.69B |
| Net Debt | -424M -490M -395M -363M -682M -46.63B -693M -4.64B -1.82B -23.36B -1.84B -1.8B -77.27B | -556M -643M -519M -477M -896M -61.24B -910M -6.1B -2.39B -30.67B -2.41B -2.36B -101B |
| Date | Price | Change |
|---|---|---|
| 07/08/26 | €23.92 | +0.93% |
| 06/08/26 | €23.70 | -0.04% |
| 05/08/26 | €23.71 | -0.34% |
| 04/08/26 | €23.79 | +0.17% |
| 03/08/26 | €23.75 | -1.25% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NAMS Stock
- KH6 Stock
Select your edition
All financial news and data tailored to specific country editions
